Human Fibrinogen - Pharmacokinetics

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Fibrinogen Deficiency
Interventions
BIOLOGICAL

Human Fibrinogen Concentrate

Single intravenous infusion of 70 mg/kg body weight

Trial Locations (15)

10021

Contact CSL Behring for facility details, New York

15232

Contact CSL Behring for facility details, Pittsburgh

20122

Contact CSL Behring for facility details, Milan

33701

Contact CSL Behring for facility details, St. Petersburg

35128

Contact CSL Behring for facility details, Padua

36100

Contact CSL Behring for facility details, Vicenza

50134

Contact CSL Behring for facility details, Florence

60614

Contact CSL Behring for facility details, Chicago

80045

Contact CSL Behring for facility details, Aurora

80122

Contact CSL Behring for facility details, Napoli

90134

Contact CSL Behring for facility details, Palermo

04074-9308

Contact CSL Behring for facility details, Scarborough

09100

Contact CSL Behring for facility details, Cagliari

00161

Contact CSL Behring for facility details, Rome

07100

Contact CSL Behring for facility details, Sassari

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CSL Behring

INDUSTRY